Cardiff Oncology Payables and Accrued Expenses (Quarterly) Insights

Cardiff Oncology, Inc. (CRDF)

2.90 -0.07 (-2.36%) USD | NASDAQ | Jan 23, 16:00

2.905 0.00 (0.00%) After-Hours: 20:00

View Payables and Accrued Expenses (Quarterly) for CRDF.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial

Agenus, Inc.	Upgrade
AIM ImmunoTech, Inc.	Upgrade
Perspective Therapeutics, Inc.	Upgrade
Protalix Biotherapeutics, Inc.	Upgrade
Armata Pharmaceuticals, Inc.	Upgrade